Concepedia

Michael T. Fisher

MT

Statistics

Publications

18

Citations

821

H-Index

15

Active since

1983

Affiliations

Virginia Commonwealth University Medical Center(Current)

Virginia Tech

Altria (United States)

University of Basel

Michael T. Fisher is an author at Virginia Commonwealth University Medical Center specializing in life sciences, immunology, and toxicology.

ORCID

Publications per year

1983–2021

18

Publications

18

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

Robert J. McKallip, Catherine Lombard, Michael T. Fisher et al. · Blood · 2002 · 287 citations · Full text

, , +8

Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays

Ahmet Zeytun, Robert J. McKallip, Michael T. Fisher et al. · Toxicology · 2002 · 66 citations

, , +9

Sources of and technical approaches for the abatement of tobacco specific nitrosamine formation in moist smokeless tobacco products

Michael T. Fisher, Cliff B. Bennett, A. J. Hayes et al. · Food and Chemical Toxicology · 2011 · 54 citations

, , +11

Homozygosity and Heterozygosity in three Populations of Rivulus marmoratus

D. Scott Taylor, Michael T. Fisher, Bruce J. Turner · Environmental Biology of Fishes · 2001 · 48 citations

, , +6

Aryl hydrocarbon receptor-dependent induction of loss of mitochondrial membrane potential in epididydimal spermatozoa by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)

Michael T. Fisher, Prakash Nagarkatti · Toxicology Letters · 2005 · 48 citations

, , +16

1–5 of 18